Stueland Katherine
SEC CIK 1689575 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| WGS | GeneDx Holdings Corp. | CEO, Dir | 126.0K | $100.0K | $39.36M | 93 | 2022-11-28 | 2026-09-16 |
Most active insiders at WGS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Meister Keith A. | Dir, 10% | $74.03M | — |
| 2 | Casdin Capital, LLC | Dir, 10% | $32.57M | — |
| 3 | Stueland Katherine | CEO, Dir | — | $12.90M |
| 4 | RUCH JOSHUA | Dir | — | $6.09M |
| 5 | Feeley Kevin | CFO | — | $4.07M |
| 6 | Dechairo Bryan | COO | — | $850.6K |
| 7 | Fuchs Thomas | Dir | — | — |
| 8 | Leproust Emily M. | Dir | — | — |
| 9 | Ryan Jason | Dir | — | — |
| 10 | Casdin Eli | Dir, 10% | — | — |
Transactions 93
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-18 16:43 | 2026-09-16 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | M - OptEx | $0.00 | +18.8K | 126.0K | +17% | $0 |
| DM | 2026-09-18 16:43 | 2026-09-16 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | S - Sale+OE | $97.61 | -10.5K | 115.5K | -8% | -$1.03M |
| D | 2026-09-11 16:13 | 2026-09-09 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | M - OptEx | $0.00 | +6,547 | 110.9K | +6% | $0 |
| D | 2026-09-11 16:13 | 2026-09-09 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | S - Sale+OE | $84.22 | -3,692 | 107.2K | -3% | -$310.9K |
| D | 2026-06-18 16:09 | 2026-06-16 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | M - OptEx | $0.00 | +18.8K | 114.9K | +20% | $0 |
| DM | 2026-06-18 16:09 | 2026-06-16 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | S - Sale+OE | $60.77 | -10.5K | 104.4K | -9% | -$638.1K |
| D | 2026-06-11 16:11 | 2026-06-09 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | M - OptEx | $0.00 | +6,546 | 99.8K | +7% | $0 |
| D | 2026-06-11 16:11 | 2026-06-09 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | S - Sale+OE | $53.77 | -3,639 | 96.1K | -4% | -$195.7K |
| D | 2026-05-01 16:28 | 2026-04-29 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | M - OptEx | $0.00 | +3,874 | 95.4K | +4% | $0 |
| DM | 2026-05-01 16:28 | 2026-04-29 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | S - Sale+OE | $65.19 | -2,172 | 93.2K | -2% | -$141.6K |
| DM | 2026-03-30 | 2026-03-26 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | S - Sale+OE | $63.17 | -46.9K | 101.4K | -32% | -$2.96M |
| D | 2026-03-30 | 2026-03-26 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | M - OptEx | $0.00 | +80.0K | 138.4K | +137% | $0 |
| DM | 2026-03-17 | 2026-03-15+ | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | M - OptEx | $0.00 | +30.7K | 75.6K | +68% | $0 |
| DM | 2026-03-17 | 2026-03-16 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | S - Sale+OE | $76.80 | -17.2K | 68.4K | -20% | -$1.32M |
| D | 2026-03-11 | 2026-03-09 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | M - OptEx | $0.00 | +6,546 | 48.6K | +16% | $0 |
| D | 2026-03-11 | 2026-03-09 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | S - Sale+OE | $86.75 | -3,678 | 45.0K | -8% | -$319.1K |
| 2026-03-09 | 2026-03-06 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | A - Grant | $88.11 | +3,404 | 42.1K | +9% | +$299.9K | |
| D | 2026-03-05 | 2026-03-03 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | A - Grant | $0.00 | +47.7K | 64.1K | +290% | $0 |
| DM | 2026-03-05 | 2026-03-04 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | S - Sale | $78.61 | -25.5K | 38.7K | -40% | -$2.00M |
| D | 2026-02-02 | 2026-01-29 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | M - OptEx | $0.00 | +3,874 | 18.1K | +27% | $0 |
| D | 2026-02-02 | 2026-01-29 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | S - Sale+OE | $94.00 | -1,653 | 16.5K | -9% | -$155.4K |
| DM | 2025-12-18 | 2025-12-16 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | S - Sale+OE | $143.89 | -10.9K | 14.7K | -43% | -$1.56M |
| D | 2025-12-18 | 2025-12-16 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | M - OptEx | $0.00 | +18.8K | 25.1K | +296% | $0 |
| D | 2025-12-11 | 2025-12-09 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | S - Sale+OE | $159.28 | -3,639 | 6,344 | -36% | -$579.6K |
| D | 2025-12-11 | 2025-12-09 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | M - OptEx | $0.00 | +6,547 | 9,983 | +191% | $0 |
| DM | 2025-10-31 | 2025-10-29 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | S - Sale+OE | $136.54 | -2,158 | 3,436 | -39% | -$294.7K |
| D | 2025-10-31 | 2025-10-29 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | M - OptEx | $0.00 | +3,874 | 5,594 | +225% | $0 |
| M | 2025-10-01 | 2025-09-30 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | S - Sale | $108.17 | -12.9K | 2,701 | -83% | -$1.39M |
| D | 2025-09-18 | 2025-09-16 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | S - Sale+OE | $121.47 | -10.5K | 14.6K | -42% | -$1.28M |
| D | 2025-09-18 | 2025-09-16 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | M - OptEx | $0.00 | +18.8K | 25.1K | +296% | $0 |
| DM | 2025-09-11 | 2025-09-09 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | S - Sale+OE | $128.06 | -3,657 | 6,329 | -37% | -$468.3K |
| D | 2025-09-11 | 2025-09-09 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | M - OptEx | $0.00 | +6,546 | 9,986 | +190% | $0 |
| D | 2025-07-31 | 2025-07-29 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | S - Sale+OE | $105.31 | -2,154 | 3,440 | -39% | -$226.8K |
| D | 2025-07-31 | 2025-07-29 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | M - OptEx | $0.00 | +3,874 | 5,594 | +225% | $0 |
| 2025-07-11 | 2025-07-09 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | S - Sale | $93.00 | -3,220 | 1,720 | -65% | -$299.5K | |
| M | 2025-07-03 | 2025-07-01 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | S - Sale | $90.94 | -9,657 | 4,940 | -66% | -$878.2K |
| D | 2025-06-18 | 2025-06-16 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | M - OptEx | $0.00 | +18.8K | 25.1K | +295% | $0 |
| D | 2025-06-18 | 2025-06-16 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | S - Sale+OE | $64.77 | -10.5K | 14.6K | -42% | -$680.1K |
| D | 2025-06-11 | 2025-06-09 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | M - OptEx | $0.00 | +6,547 | 9,987 | +190% | $0 |
| D | 2025-06-11 | 2025-06-09 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | S - Sale+OE | $72.55 | -3,639 | 6,348 | -36% | -$264.0K |
| D | 2025-05-01 | 2025-04-29 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | M - OptEx | $0.00 | +3,874 | 5,594 | +225% | $0 |
| D | 2025-05-01 | 2025-04-29 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | S - Sale+OE | $113.09 | -2,154 | 3,440 | -39% | -$243.6K |
| M | 2025-04-10 | 2025-04-09 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | S - Sale | $89.62 | -46.6K | 27.4K | -63% | -$4.18M |
| DM | 2025-03-28 | 2025-03-26 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | S - Sale+OE | $95.62 | -46.6K | 48.3K | -49% | -$4.45M |
| D | 2025-03-28 | 2025-03-26 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | M - OptEx | $0.00 | +80.0K | 94.9K | +538% | $0 |
| DM | 2025-03-17 | 2025-03-13+ | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | S - Sale+OE | $96.04 | -11.6K | 14.9K | -44% | -$1.12M |
| D | 2025-03-17 | 2025-03-16 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | M - OptEx | $0.00 | +18.8K | 25.4K | +281% | $0 |
| D | 2025-03-11 | 2025-03-09 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | M - OptEx | $0.00 | +6,546 | 10.5K | +166% | $0 |
| D | 2025-03-11 | 2025-03-10 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | S - Sale+OE | $94.73 | -2,731 | 7,752 | -26% | -$258.7K |
| D | 2025-01-31 | 2025-01-29 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | M - OptEx | $0.00 | +3,874 | 5,594 | +225% | $0 |
| D | 2025-01-31 | 2025-01-29 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | S - Sale+OE | $78.48 | -1,657 | 3,937 | -30% | -$130.0K |
| M | 2025-01-10 | 2025-01-07 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | S - Sale | $94.48 | -51.4K | 1,720 | -97% | -$4.86M |
| M | 2025-01-06 | 2025-01-02 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | S - Sale | $78.18 | -18.0K | 68.5K | -21% | -$1.41M |
| D | 2024-12-18 | 2024-12-16 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | S - Sale+OE | $76.75 | -10.5K | 71.1K | -13% | -$806.0K |
| D | 2024-12-18 | 2024-12-16 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | M - OptEx | $0.00 | +18.8K | 81.6K | +30% | $0 |
| D | 2024-12-11 | 2024-12-09 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | M - OptEx | $0.00 | +6,547 | 66.6K | +11% | $0 |
| D | 2024-12-11 | 2024-12-09 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | S - Sale+OE | $76.37 | -3,661 | 62.9K | -6% | -$279.6K |
| M | 2024-11-19 | 2024-11-15+ | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | S - Sale | $70.41 | -45.4K | 81.5K | -36% | -$3.20M |
| D | 2024-10-31 | 2024-10-29 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | M - OptEx | $0.00 | +3,874 | 107.6K | +4% | $0 |
| D | 2024-10-31 | 2024-10-29 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | S - Sale+OE | $66.60 | -2,154 | 105.4K | -2% | -$143.5K |
| D | 2024-09-18 | 2024-09-16 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | S - Sale+OE | $37.59 | -10.5K | 103.7K | -9% | -$394.7K |
| D | 2024-09-18 | 2024-09-16 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | M - OptEx | $0.00 | +18.8K | 114.2K | +20% | $0 |
| D | 2024-09-11 | 2024-09-09 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | S - Sale+OE | $33.33 | -3,639 | 95.5K | -4% | -$121.3K |
| D | 2024-09-11 | 2024-09-09 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | M - OptEx | $0.00 | +6,546 | 99.1K | +7% | $0 |
| D | 2024-07-31 | 2024-07-29 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | M - OptEx | $0.00 | +3,874 | 94.7K | +4% | $0 |
| D | 2024-07-31 | 2024-07-29 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | S - Sale+OE | $33.54 | -2,154 | 92.5K | -2% | -$72.2K |
| D | 2024-06-18 | 2024-06-17 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | S - Sale+OE | $28.31 | -7,683 | 90.8K | -8% | -$217.5K |
| D | 2024-06-18 | 2024-06-16 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | M - OptEx | $0.00 | +18.8K | 98.5K | +24% | $0 |
| D | 2024-06-11 | 2024-06-09 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | M - OptEx | $0.00 | +6,546 | 82.4K | +9% | $0 |
| D | 2024-06-11 | 2024-06-10 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | S - Sale+OE | $24.92 | -2,652 | 79.8K | -3% | -$66.1K |
| D | 2024-04-30 | 2024-04-29 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | M - OptEx | $0.00 | +15.5K | 82.2K | +23% | $0 |
| D | 2024-04-30 | 2024-04-29 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | S - Sale+OE | $11.04 | -6,325 | 75.9K | -8% | -$69.8K |
| D | 2024-03-19 | 2024-03-16 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | M - OptEx | $0.00 | +18.8K | 75.3K | +33% | $0 |
| D | 2024-03-19 | 2024-03-18 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | S - Sale+OE | $10.59 | -8,559 | 66.7K | -11% | -$90.6K |
| 2024-03-13 | 2024-03-12 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | S - Sale | $9.21 | -2,618 | 56.5K | -4% | -$24.1K | |
| D | 2024-03-12 | 2024-03-09 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | M - OptEx | $0.00 | +6,547 | 59.1K | +12% | $0 |
| D | 2023-12-19 | 2023-12-16 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | M - OptEx | $0.00 | +18.8K | 64.3K | +41% | $0 |
| D | 2023-12-19 | 2023-12-18 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | S - Sale+OE | $2.16 | -11.7K | 52.6K | -18% | -$25.3K |
| D | 2023-12-12 | 2023-12-09 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | M - OptEx | $0.00 | +6,546 | 49.2K | +15% | $0 |
| D | 2023-12-12 | 2023-12-11 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | S - Sale+OE | $1.61 | -3,673 | 45.6K | -7% | -$5,914 |
| D | 2023-09-19 | 2023-09-16 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | M - OptEx | — | +18.8K | 53.4K | +54% | — |
| D | 2023-09-19 | 2023-09-18 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | S - Sale+OE | $4.16 | -10.8K | 42.7K | -20% | -$44.7K |
| D | 2023-09-12 | 2023-09-11 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | S - Sale+OE | $4.62 | -2,675 | 34.7K | -7% | -$12.4K |
| D | 2023-09-12 | 2023-09-09 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | M - OptEx | — | +6,547 | 37.4K | +21% | — |
| DM | 2023-06-21 | 2023-06-20 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | S - Sale+OE | $6.37 | -7,965 | 31.1K | -20% | -$50.7K |
| D | 2023-06-21 | 2023-06-16 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | M - OptEx | — | +18.8K | 38.8K | +94% | — |
| D | 2023-06-13 | 2023-06-12 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | S - Sale+OE | $6.49 | -2,674 | 20.0K | -12% | -$17.4K |
| D | 2023-06-13 | 2023-06-09 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | M - OptEx | — | +6,546 | 22.7K | +41% | — |
| 2023-05-18 | 2023-05-16 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | S - Sale | $6.50 | -8,685 | 16.2K | -35% | -$56.5K | |
| D | 2023-05-02 | 2023-04-29 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO | M - OptEx | $0.00 | -511.4K | 819.9K | -38% | $0 |
| D | 2023-03-13 | 2023-03-09 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO | M - OptEx | — | +216.0K | 401.2K | +117% | — |
| D | 2023-03-13 | 2023-03-10 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO | S - Sale+OE | $0.36 | -92.6K | 308.6K | -23% | -$33.4K |
| 2022-11-28 | 2022-11-28 | WGS | GeneDx Holdings Corp. | Stueland Katherine | CEO, Dir | P - Purchase | $0.54 | +185.2K | 185.2K | New | +$100.0K |
Purchase Sale Sale after option exercise All abbreviations